Compile Data Set for Download or QSAR
Report error Found 84 Enz. Inhib. hit(s) with all data for entry = 8035
TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230694(US9340530, 28)
Affinity DataIC50: 0.900nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230682(US9340530, 20b | US9340530, 20a)
Affinity DataIC50: 0.900nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230745(US9340530, 29b)
Affinity DataIC50: 1nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230742(US9340530, 77)
Affinity DataIC50: 1.20nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230692(US9340530, 26)
Affinity DataIC50: 1.20nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230688(US9340530, 23b | US9340530, 23a)
Affinity DataIC50: 1.20nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230684(US9340530, 21b | US9340530, 21a)
Affinity DataIC50: 1.20nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230682(US9340530, 20b | US9340530, 20a)
Affinity DataIC50: 1.20nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230708(US9340530, 43)
Affinity DataIC50: 1.30nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230698(US9340530, 32)
Affinity DataIC50: 1.40nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230743(US9340530, 78)
Affinity DataIC50: 1.5nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230709(US9340530, 44)
Affinity DataIC50: 1.60nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230660(US9340530, 1)
Affinity DataIC50: 1.60nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230727(US9340530, 62)
Affinity DataIC50: 1.70nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230686(US9340530, 22b | US9340530, 22a)
Affinity DataIC50: 1.90nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230670(US9340530, 8)
Affinity DataIC50: 2nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230695(US9340530, 29a)
Affinity DataIC50: 2.10nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230704(US9340530, 39)
Affinity DataIC50: 2.20nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230686(US9340530, 22b | US9340530, 22a)
Affinity DataIC50: 2.20nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230728(US9340530, 63)
Affinity DataIC50: 2.30nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230741(US9340530, 76)
Affinity DataIC50: 2.30nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230707(US9340530, 42)
Affinity DataIC50: 2.40nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230737(US9340530, 72)
Affinity DataIC50: 2.5nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230684(US9340530, 21b | US9340530, 21a)
Affinity DataIC50: 2.5nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230715(US9340530, 50)
Affinity DataIC50: 2.70nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230730(US9340530, 65)
Affinity DataIC50: 2.70nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230666(US9340530, 4)
Affinity DataIC50: 2.70nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230677(US9340530, 15)
Affinity DataIC50: 2.70nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230722(US9340530, 57)
Affinity DataIC50: 2.80nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230729(US9340530, 64)
Affinity DataIC50: 2.90nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230723(US9340530, 58)
Affinity DataIC50: 3nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230681(US9340530, 19)
Affinity DataIC50: 3nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230724(US9340530, 59)
Affinity DataIC50: 3nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230713(US9340530, 48)
Affinity DataIC50: 3nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230688(US9340530, 23b | US9340530, 23a)
Affinity DataIC50: 3.10nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230711(US9340530, 46)
Affinity DataIC50: 3.10nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230696(US9340530, 31 | US9340530, 30)
Affinity DataIC50: 3.10nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230691(US9340530, 25)
Affinity DataIC50: 3.30nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230738(US9340530, 73)
Affinity DataIC50: 3.30nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230680(US9340530, 18)
Affinity DataIC50: 3.30nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230725(US9340530, 60)
Affinity DataIC50: 3.40nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230673(US9340530, 11)
Affinity DataIC50: 3.40nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230731(US9340530, 66)
Affinity DataIC50: 3.5nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230732(US9340530, 67)
Affinity DataIC50: 3.70nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230705(US9340530, 40)
Affinity DataIC50: 3.90nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230702(US9340530, 36)
Affinity DataIC50: 4.10nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230717(US9340530, 52)
Affinity DataIC50: 4.30nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230701(US9340530, 35)
Affinity DataIC50: 4.30nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230710(US9340530, 45)
Affinity DataIC50: 4.40nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM230671(US9340530, 9)
Affinity DataIC50: 4.5nMAssay Description:HEK 293 Cells were grown in media containing DMEM, 10% FBS pen/strep/L-Glutamine and non-essential amino acids. The cells were plated in 384-well PDL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2017
Entry Details
Go to US Patent

Displayed 1 to 50 (of 84 total ) | Next | Last >>
Jump to: